Plymouth, MI, United States of America

Sierra Oncology, Inc.


USPTO Granted Patents = 4


Trademarks = 1

Forward Citations = 6

Loading Chart...
Loading Chart...

17 inventors (with patents filed for the assignee):

goldMedal Matthew Robert Warr (3 out of 6 patents)

silverMedal James Andrew Whitney (3 out of 6 patents)

bronzeMedal Henry G Morrison (2 out of 21 patents)

4.  Bing Shi (2 out of 41 patents)

5.  Ernest A Carra (2 out of 20 patents)

6.  Fang Wang (2 out of 26 patents)

7.  Dimitrios Stefanidis (2 out of 29 patents)

8.  Jeffrey N Hemenway (2 out of 7 patents)

9.  Yan Xin (2 out of 6 patents)

10.  Brandon H Brown (2 out of 3 patents)

11.  Troy Reynolds (2 out of 3 patents)

12.  Brian Koh (1 out of 1 patent)

13.  Igor Theurl (1 out of 1 patent)

14.  Ryan Hansen (1 out of 4 patents)

15.  Kenna Lynn Anderes (1 out of 1 patent)


4 patents:

Company Overview
Sierra Oncology is a clinical-stage biopharmaceutical company focused on advancing targeted therapeutics for the treatment of solid tumor patients. Their lead drug candidate, SRA737, is being evaluated in multiple clinical studies for the treatment of various types of cancer. With a dedicated team of researchers and scientists, Sierra Oncology is committed to developing innovative therapies that have the potential to improve outcomes for cancer patients worldwide.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

4 Patents

#50 in Plymouth, MI

#2,023 in Michigan

#60,671 in US

Plymouth, MI (US)
Plymouth, MI, United States of America
Forward Citations = 6

17 inventors:

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Sierra Oncology, Inc.. Retrieved from https://idiyas.com/company/sierra-oncology

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…